Log in

NASDAQ:MSONMisonix Stock Price, Forecast & News

$13.33
+0.27 (+2.07 %)
(As of 07/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$12.83
Now: $13.33
$13.69
50-Day Range
$10.09
MA: $13.29
$15.84
52-Week Range
$6.71
Now: $13.33
$26.55
Volume41,038 shs
Average Volume125,809 shs
Market Capitalization$231.41 million
P/E RatioN/A
Dividend YieldN/A
Beta1.27
Misonix, Inc., together with its subsidiaries, designs, develops, manufactures, and markets therapeutic ultrasonic medical devices in the United States, the Americas, Europe, Middle East, Asia Pacific, Africa, and internationally. The company offers BoneScalpel, an ultrasonic bone cutting and sculpting system for surgical procedures involving the precise cutting of bone while sparing soft tissue; SonaStar, a surgical aspirator that is used to emulsify and remove soft and hard tumors primarily in the neuro and general surgery field; and SonicOne, an ultrasonic cleansing and debridement system, which provides tissue specific debridement and cleansing of wounds and burns for the removal of devitalized tissue and fibrin deposits while sparing viable cells. Its products are used in various clinical specialties, such as neurosurgery, orthopedic surgery, plastic surgery, wound care, and maxillo-facial surgical applications. The company sells its products through sales representatives and distributors. Misonix, Inc. was founded in 1959 and is based in Farmingdale, New York.
Read More
Misonix logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.36 out of 5 stars


Industry, Sector and Symbol

Industry Laboratory apparatus & furniture
Sub-IndustryN/A
Current SymbolNASDAQ:MSON
CUSIPN/A
Phone631-694-9555

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$38.85 million
Book Value$2.25 per share

Profitability

Net Income$-7,390,000.00

Miscellaneous

Employees118
Market Cap$231.41 million
Next Earnings Date8/12/2020 (Estimated)
OptionableNot Optionable

Receive MSON News and Ratings via Email

Sign-up to receive the latest news and ratings for MSON and its competitors with MarketBeat's FREE daily newsletter.

Misonix (NASDAQ:MSON) Frequently Asked Questions

How has Misonix's stock been impacted by COVID-19 (Coronavirus)?

Misonix's stock was trading at $10.68 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, MSON stock has increased by 24.8% and is now trading at $13.33. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Misonix?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Misonix in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Misonix.

When is Misonix's next earnings date?

Misonix is scheduled to release its next quarterly earnings announcement on Wednesday, August 12th 2020. View our earnings forecast for Misonix.

How were Misonix's earnings last quarter?

Misonix, Inc. (NASDAQ:MSON) issued its quarterly earnings data on Monday, May, 11th. The medical equipment provider reported ($0.34) EPS for the quarter, missing analysts' consensus estimates of ($0.30) by $0.04. The medical equipment provider earned $17.90 million during the quarter. Misonix had a negative net margin of 19.18% and a negative return on equity of 9.13%. View Misonix's earnings history.

What price target have analysts set for MSON?

2 brokerages have issued twelve-month price objectives for Misonix's stock. Their forecasts range from $13.00 to $22.00. On average, they expect Misonix's stock price to reach $17.67 in the next year. This suggests a possible upside of 32.5% from the stock's current price. View analysts' price targets for Misonix.

Has Misonix been receiving favorable news coverage?

Headlines about MSON stock have trended negative this week, according to InfoTrie Sentiment Analysis. The research group rates the sentiment of news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Misonix earned a coverage optimism score of -2.1 on InfoTrie's scale. They also assigned media headlines about the medical equipment provider a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the next several days. View the latest news about Misonix.

Who are some of Misonix's key competitors?

What other stocks do shareholders of Misonix own?

Who are Misonix's key executives?

Misonix's management team includes the following people:
  • Mr. Stavros George Vizirgianakis, Pres, CEO & Director (Age 49)
  • Mr. Joseph P. Dwyer, CFO, Treasurer & Sec. (Age 63)
  • Mr. Robert Scott Ludecker, Sr. VP of Global Sales & Marketing (Age 52)
  • Ms. Sharon W. Klugewicz, Chief Operating Officer (Age 51)
  • Mr. John J. Salerno, VP of Quality and Regulatory Affairs & Chief Compliance Officer (Age 64)

What is Misonix's stock symbol?

Misonix trades on the NASDAQ under the ticker symbol "MSON."

How do I buy shares of Misonix?

Shares of MSON can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Misonix's stock price today?

One share of MSON stock can currently be purchased for approximately $13.33.

How big of a company is Misonix?

Misonix has a market capitalization of $231.41 million and generates $38.85 million in revenue each year. Misonix employs 118 workers across the globe.

What is Misonix's official website?

The official website for Misonix is www.misonix.com.

How can I contact Misonix?

Misonix's mailing address is 1938 NEW HIGHWAY, FARMINGDALE NY, 11735. The medical equipment provider can be reached via phone at 631-694-9555.

This page was last updated on 7/6/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.